Sunrest Lifescience Limited (NSE:SUNREST)
India · Delayed Price · Currency is INR 38.05
+0.85 (2.28%)
Sep 11, 2026, 3:19 PM IST
Sunrest Lifescience Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 27.65 | 17.38 | 2.9 | 4.5 | 4.8 |
Cash & Short-Term Investments | 27.65 | 17.38 | 2.9 | 4.5 | 4.8 |
Cash Growth | 59.04% | 500.45% | -35.65% | -6.27% | 28.65% |
Accounts Receivable | 324.63 | 363.65 | 149.98 | 108.57 | 93.47 |
Receivables | 324.63 | 363.65 | 152.18 | 108.57 | 94.97 |
Inventory | 174.6 | 101.24 | 50.51 | 39.41 | 22.95 |
Prepaid Expenses | 0.02 | 0.18 | 0.14 | 0.1 | - |
Other Current Assets | 97.8 | 53.46 | 42.59 | 10.46 | 2.77 |
Total Current Assets | 624.7 | 535.92 | 248.31 | 163.04 | 125.48 |
Property, Plant & Equipment | 84.6 | 43.56 | 2.54 | 3.51 | 4.67 |
Long-Term Investments | - | - | 0.17 | 0.17 | - |
Other Intangible Assets | 0.89 | 0.08 | 0.07 | - | - |
Long-Term Deferred Tax Assets | 3.65 | 4.06 | 0.22 | 0.15 | 0.05 |
Other Long-Term Assets | 0.31 | 2.88 | 0.25 | 0.26 | -0 |
Total Assets | 714.14 | 586.5 | 251.56 | 167.12 | 130.2 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 210.21 | 229.34 | 37.96 | 86.18 | 79.33 |
Accrued Expenses | 11.77 | 7.02 | 3.79 | 6.15 | 4.03 |
Short-Term Debt | 50.11 | 62.51 | 25.59 | - | - |
Current Portion of Long-Term Debt | 4.91 | 0.67 | 1.39 | 1.46 | 1.46 |
Current Income Taxes Payable | 17.64 | 9.94 | 3.74 | 7.1 | 2.72 |
Other Current Liabilities | -0 | - | 2.62 | 15.12 | 1.01 |
Total Current Liabilities | 294.63 | 309.47 | 75.08 | 116.01 | 88.55 |
Long-Term Debt | 119.57 | 57.33 | 34.62 | 19.97 | 30.92 |
Other Long-Term Liabilities | 3.7 | 3.4 | - | -0 | -0 |
Total Liabilities | 417.9 | 370.2 | 109.7 | 135.98 | 119.48 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 42.91 | 42.91 | 42.91 | 30 | 0.1 |
Additional Paid-In Capital | 95.55 | 95.55 | - | - | - |
Retained Earnings | 64.61 | 23.45 | 98.94 | 1.14 | 10.62 |
Comprehensive Income & Other | 1.2 | 1.2 | - | - | - |
Total Common Equity | 204.27 | 163.11 | 141.85 | 31.14 | 10.72 |
Minority Interest | 91.97 | 53.19 | - | - | - |
Shareholders' Equity | 296.24 | 216.3 | 141.85 | 31.14 | 10.72 |
Total Liabilities & Equity | 714.14 | 586.5 | 251.56 | 167.12 | 130.2 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 174.59 | 120.5 | 61.6 | 21.43 | 32.38 |
Net Cash (Debt) | -146.94 | -103.12 | -58.7 | -16.93 | -27.58 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -34.24 | -24.03 | -17.67 | -5.64 | -9.19 |
Filing Date Shares Outstanding | 4.29 | 4.29 | 4.29 | 3 | 3 |
Total Common Shares Outstanding | 4.29 | 4.29 | 4.29 | 3 | 3 |
Working Capital | 330.07 | 226.45 | 173.23 | 47.03 | 36.93 |
Book Value Per Share | 47.60 | 38.01 | 33.06 | 10.38 | 3.57 |
Tangible Book Value | 203.39 | 163.03 | 141.79 | 31.14 | 10.72 |
Tangible Book Value Per Share | 47.40 | 37.99 | 33.04 | 10.38 | 3.57 |
Buildings | 30.51 | 15.08 | - | - | - |
Machinery | 69.07 | 35.94 | 5.25 | 5.27 | 5.13 |